Atellica® IM and ADVIA Centaur® Squamous Cell Carcinoma (SCC) Assay
The Siemens Healthineers SCC assay, available on the Atellica ® IM Analyzer and ADVIA Centaur ® Immunoassay Systems, is a valuable tool for the assessment and monitoring of squamous cell carcinoma of the head and neck, lung, and cervix. Not available for sale in USA.
Atellica ® IM SCC ASSAY
ADVIA Centaur ® SCC assay
Receive your quote directly from the manufacturer.
Squamous Cell Carcinoma Antigen (SCCA) concentrations are elevated in the blood of patients with cervical, lung, and head and neck cancers. Serial SCCA measurements aid in the assessment of disease recurrence, residual disease following treatment, and response to therapy. In SCC of the lung, head and neck, SCCA1 and SCCA2 are co-expressed in moderately and well-differentiated tumors. For optimal clinical sensitivity, assays should be capable of detecting both SCCA1 and SCCA2.
The Siemens Healthineers SCC assay can accurately detect SCCA concentrations, which in conjunction with other clinical and laboratory findings, aids clinicians in treating patients with squamous cell carcinomas.
The SCC Assay delivers:
- Rapid and precise measurement of SCC antigen concentrations to monitor disease progression and treatment
- Confidence in results with an assay that detects equimolar SCCA1 and SCCA2, enabling measurement of total SCCA
- Trusted Acridinium Ester, technology, coupled with two highly specific monoclonal antibodies
